{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:58:53Z","timestamp":1787497133657,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Automatic analyzers simplify processes and may help improve standardization. The first automated analyzer based on mass spectrometry is available and offers a panel for monitoring cyclosporin A, tacrolimus, sirolimus, and everolimus. Method comparisons and evaluation tests are presented to verify the capability of the Cascadion system for use in a clinical laboratory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Sample preparation and measurements were performed using the Cascadion clinical analyzer. More than 1000 measurement values of patient samples were compared with an in vitro diagnostic\u2013certified assay run on a liquid chromatography tandem mass spectrometry instrument. Precision and accuracy were determined using commercial quality control and external quality assessment (EQA) samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A good correlation between the 2 instruments was observed (Pearson correlation\n                      <jats:italic toggle=\"yes\">r =<\/jats:italic>\n                      0.956\u20130.996). Deming regression revealed 95% confidence intervals of slopes and intercepts covering the values 1 and 0, for sirolimus and everolimus, respectively, indicating equivalence of both measuring systems. However, for cyclosporin A, a bias was observed and confirmed using a Bland\u2013Altman plot (\u22129.1%). Measurement repeatability and intermediate measurement precision were appropriate showing coefficients of variation of 0.9%\u20136.1% and 2.0%\u20135.3%, respectively. Accuracy according to internal quality controls was 85%\u2013111% and 81%\u2013100% in the EQA samples of Reference Institute of Bioanalytics and Laboratory of the Government Chemist, respectively. High robustness was found with regard to the linearity of the calibration lines (linear regression coefficient\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      &gt; 0.99). Carryover was negligible (0.1%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The Cascadion automatic analyzer produced convincing results in the measurement of patient, control, and EQA samples. The throughput was sufficient for routine use. Overall, it can be used as an alternative to open liquid chromatography tandem mass spectrometry instruments for immunosuppressant monitoring, simplifying processes without the need for specially trained personnel.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001051","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T12:03:32Z","timestamp":1666872212000},"page":"14-19","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Immunosuppressant Monitoring\u2014Performance of the First Mass Spectrometry\u2013Based Automated Clinical Analyzer Cascadion"],"prefix":"10.1097","volume":"45","author":[{"given":"Denis","family":"Grote-Koska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Czajkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Staaden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korbinian","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/01971528108062989","article-title":"A radioimmunoassay to measure cyclosporin A in plasma and serum","volume":"2","author":"Donatsch","year":"1981","journal-title":"J Immunoassay"},{"key":"R2-20260519","first-page":"431","article-title":"High pressure liquid chromatographic determination of cyclosporin-A in human plasma","volume":"37","author":"Leyland-Jones","year":"1982","journal-title":"Res Commun Chem Pathol Pharmacol."},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00007691-200404000-00023","article-title":"Therapeutic drug monitoring of immunosuppressant drugs by high-performance liquid chromatography-mass spectrometry","volume":"26","author":"Taylor","year":"2004","journal-title":"Ther Drug Monit."},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FTD.0b013e318274827d","article-title":"Evaluation of a novel commercial assay for the determination of cyclosporine a, tacrolimus, sirolimus, and everolimus by liquid chromatography\u2013tandem mass spectrometric assay","volume":"35","author":"Becker","year":"2013","journal-title":"Ther Drug Monit."},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/FTD.0000000000000139","article-title":"Performance of the new RapidFire System for therapeutic monitoring of immunosuppressants","volume":"37","author":"Grote-Koska","year":"2015","journal-title":"Ther Drug Monit."},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/clinchem\/45.3.371","article-title":"Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is it?","volume":"45","author":"Steimer","year":"1999","journal-title":"Clin Chem."},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/00365513.2022.2056858","article-title":"Challenged comparison of tacrolimus assays","volume":"82","author":"Cremers","year":"2022","journal-title":"Scand J Clin Lab Invest."},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/FTD.0b013e3181d46386","article-title":"Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assay","volume":"32","author":"Wallemacq","year":"2010","journal-title":"Ther Drug Monit."},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.plabm.2017.03.001","article-title":"Analytical performance evaluation of the Elecsys\u00ae Cyclosporine and Elecsys\u00ae Tacrolimus assays on the cobas e411 analyzer","volume":"8","author":"Sasano","year":"2017","journal-title":"Pract Lab Med."},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1373\/clinchem.2011.172080","article-title":"The need for standardization of tacrolimus assays","volume":"57","author":"Levine","year":"2011","journal-title":"Clin Chem."},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clinbiochem.2018.09.012","article-title":"Traceability of immunosuppressant's mass concentration results obtained using different commercial calibrators","volume":"63","author":"Rigo-Bonnin","year":"2019","journal-title":"Clin Biochem."},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00769-014-1048-5","article-title":"A candidate reference measurement procedure for Cyclosporine A in whole blood","volume":"19","author":"Grote-Koska","year":"2014","journal-title":"Accreditation Qual Assur."},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clinbiochem.2019.11.006","article-title":"An isotope dilution LC-MS\/MS based candidate reference method for the quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human whole blood","volume":"82","author":"Taibon","year":"2020","journal-title":"Clin Biochem."},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00365513.2020.1731849","article-title":"Using ISO\/TS 20914:2019 to calculate the measurement uncertainty of immunosuppressive drugs in a clinical laboratory","volume":"80","author":"Grote-Koska","year":"2020","journal-title":"Scand J Clin Lab Invest."},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1515\/cclm-2020-0848","article-title":"Evaluation of the first immunosuppressive drug assay available on a fully automated LC-MS\/MS-based clinical analyzer suggests a new era in laboratory medicine","volume":"59","author":"Hoerber","year":"2020","journal-title":"Clin Chem Lab Med."},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/FTD.0000000000000269","article-title":"Assuring the proper analytical performance of measurement procedures for immunosuppressive drug concentrations in clinical practice: recommendations of the international association of therapeutic drug monitoring and clinical toxicology immunosuppressive drug scientific committee","volume":"38","author":"Seger","year":"2016","journal-title":"Ther Drug Monit."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:00:24Z","timestamp":1779224424000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001051","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"2022-06-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}